{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T01:23:02Z","timestamp":1769131382645,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,29]],"date-time":"2014-09-29T00:00:00Z","timestamp":1411948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,9,29]],"date-time":"2014-09-29T00:00:00Z","timestamp":1411948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/bmt.2014.202","type":"journal-article","created":{"date-parts":[[2014,9,29]],"date-time":"2014-09-29T14:56:54Z","timestamp":1412002614000},"page":"68-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of CD34+ cell dose in children who receive unrelated PBSCT with in vivo T-cell depletion for hematologic malignancies"],"prefix":"10.1038","volume":"50","author":[{"given":"J W","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S-k","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P-S","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N-G","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D-C","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H-K","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,29]]},"reference":[{"key":"BFbmt2014202_CR1","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.bbmt.2007.08.006","volume":"13","author":"M Eapen","year":"2007","unstructured":"Eapen M, Logan BR, Confer DL, Haagenson M, Wagner JE, Weisdorf DJ et al. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biol Blood Marrow Transplant 2007; 13: 1461\u20131468.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014202_CR2","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","volume":"18","author":"C Anasetti","year":"2012","unstructured":"Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med 2012; 18: 1487\u20131496.","journal-title":"N Engl J Med"},{"key":"BFbmt2014202_CR3","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.bbmt.2007.07.009","volume":"13","author":"R Meisel","year":"2007","unstructured":"Meisel R, Laws HJ, Balzer S, Bernbeck B, Kramm C, Sch\u00f6nberger S et al. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies. Biol Blood Marrow Transplant 2007; 13: 1338\u20131345.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014202_CR4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/01.tp.0000275184.41831.6d","volume":"84","author":"M Remberger","year":"2007","unstructured":"Remberger M, Ringd\u00e9n O . Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents. Transplantation 2007; 84: 551\u2013554.","journal-title":"Transplantation"},{"key":"BFbmt2014202_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/pbc.22677","volume":"56","author":"YF Lin","year":"2011","unstructured":"Lin YF, Lairson DR, Chan W, Du XL, Leung KS, Kennedy-Nasser AA et al. Children with acute leukemia: a comparison of outcomes from allogeneic blood stem cell and bone marrow transplantation. Pediatr Blood Cancer 2011; 56: 143\u2013151.","journal-title":"Pediatr Blood Cancer"},{"key":"BFbmt2014202_CR6","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1182\/blood-2012-12-469668","volume":"121","author":"R Meisel","year":"2013","unstructured":"Meisel R, Klingebiel T, Dilloo D . Peripheral blood stem cells versus bone marrow in pediatric unrelated donor stem cell transplantation. Blood 2013; 121: 863\u2013865.","journal-title":"Blood"},{"key":"BFbmt2014202_CR7","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1182\/blood-2009-03-208355","volume":"114","author":"MA Pulsipher","year":"2009","unstructured":"Pulsipher MA, Chitphakdithai P, Logan BR, Leitman SF, Anderlini P, Klein JP et al. Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. Blood 2009; 114: 2606\u20132616.","journal-title":"Blood"},{"key":"BFbmt2014202_CR8","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.bbmt.2010.04.001","volume":"16","author":"K Ka\u0142wak","year":"2010","unstructured":"Ka\u0142wak K, Porwolik J, Mielcarek M, Gorczy\u0144ska E, Owoc-Lempach J, Ussowicz M et al. Higher CD34(+) and CD3(+) cell doses in the graft promote long-term survival, and have no impact on the incidence of severe acute or chronic graft-versus-host disease after in vivo T cell-depleted unrelated donor hematopoietic stem cell transplantation in children. Biol Blood Marrow Transplant 2010; 16: 1388\u20131401.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014202_CR9","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014202_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","volume":"9","author":"SJ Lee","year":"2003","unstructured":"Lee SJ, Vogelsang G, Flowers MED . Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 215\u2013233.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014202_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/bmt.2011.3","volume":"47","author":"J Gaziev","year":"2012","unstructured":"Gaziev J, Isgr\u00f2 A, Marziali M, Daniele N, Gallucci C, Sodani P et al. Higher CD3(+) and CD34(+) cell doses in the graft increase the incidence of acute GVHD in children receiving BMT for thalassemia. Bone Marrow Transplant 2012; 47: 107\u2013114.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014202_CR12","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/bmt.2009.331","volume":"45","author":"P Tsirigotis","year":"2010","unstructured":"Tsirigotis P, Shapira MY, Or R, Bitan M, Samuel S, Gesundheit B et al. The number of infused CD34+ cells does not influence the incidence of GVHD or the outcome of allogeneic PBSC transplantation, using reduced-intensity conditioning and antithymocyte globulin. Bone Marrow Transplant 2010; 45: 1189\u20131196.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014202_CR13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1046\/j.1365-2141.2000.01838.x","volume":"108","author":"E Bah\u00e7eci","year":"2000","unstructured":"Bah\u00e7eci E, Read EJ, Leitman S, Childs R, Dunbar C, Young NS et al. CD34+ cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies. Br J Haematol 2000; 108: 408\u2013414.","journal-title":"Br J Haematol"},{"key":"BFbmt2014202_CR14","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/sj.bmt.1704042","volume":"31","author":"SK Sohn","year":"2003","unstructured":"Sohn SK, Kim JG, Kim DH, Lee NY, Suh JS, Lee KB . Impact of transplanted CD34+ cell dose in allogeneic unmanipulated peripheral blood stem cell transplantation. Bone Marrow Transplant 2003; 31: 967\u2013972.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014202_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/MPH.0b013e3181f47074","volume":"33","author":"M Gonzalez-Vicent","year":"2011","unstructured":"Gonzalez-Vicent M, Diaz MA . Higher doses of CD34+ PBPC are associated with a rapid acquisition of full donor chimerism and lower risk of relapse after allogeneic transplantation in pediatric patients with hematological malignancies. J Pediatr Hematol Oncol 2011; 33: 185\u2013189.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFbmt2014202_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.bbmt.2008.02.005","volume":"14","author":"R Nakamura","year":"2008","unstructured":"Nakamura R, Auayporn N, Smith DD, Palmer J, Sun JY, Schriber J et al. Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse rates. Biol Blood Marrow Transplant 2008; 14: 449\u2013457.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014202_CR17","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1182\/blood.V98.12.3221","volume":"98","author":"JM Zaucha","year":"2001","unstructured":"Zaucha JM, Gooley T, Bensinger WI, Heimfeld S, Chauncey TR, Zaucha R et al. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. Blood 2001; 98: 3221\u20133227.","journal-title":"Blood"},{"key":"BFbmt2014202_CR18","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/sj.leu.2402909","volume":"17","author":"M Mohty","year":"2003","unstructured":"Mohty M, Bilger K, Jourdan E, Kuentz M, Michallet M, Bourhis JH et al. Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation. Leukemia 2003; 17: 869\u2013875.","journal-title":"Leukemia"},{"key":"BFbmt2014202_CR19","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/sj.bmt.1705524","volume":"38","author":"P Sedl\u00e1cek","year":"2006","unstructured":"Sedl\u00e1cek P, Form\u00e1nkov\u00e1 R, Keslov\u00e1 P, Sr\u00e1mkov\u00e1 L, Hub\u00e1cek P, Kr\u00f3l L et al. Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8\/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin. Bone Marrow Transplant 2006; 38: 745\u2013750.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014202_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1600-0609.2008.01047.x","volume":"80","author":"M Remberger","year":"2008","unstructured":"Remberger M, Mattsson J, Hausenberger D, Schaffer M, Svahn BM, Ringd\u00e9n O . Genomic tissue typing and optimal antithymocyte globuline dose using unrelated donors results in similar survival and relapse as HLA-identical siblings in haematopoietic stem-cell transplantation for leukaemia. Eur J Haematol 2008; 80: 419\u2013428.","journal-title":"Eur J Haematol"},{"key":"BFbmt2014202_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1365-2141.2011.08615.x","volume":"153","author":"BE Shaw","year":"2011","unstructured":"Shaw BE, Apperley JF, Russell NH, Craddock C, Liakopoulou E, Potter MN et al. Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease. Br J Haematol 2011; 153: 244\u2013252.","journal-title":"Br J Haematol"},{"key":"BFbmt2014202_CR22","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S1470-2045(09)70225-6","volume":"10","author":"J Finke","year":"2009","unstructured":"Finke J, Bethge WA, Schmoor C, Ottinger HD, Stelljes M, Zander AR et al. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol 2009; 10: 855\u2013864.","journal-title":"Lancet Oncol"},{"key":"BFbmt2014202_CR23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/sj.bmt.1704054","volume":"31","author":"S Giebel","year":"2003","unstructured":"Giebel S, Giorgiani G, Martinetti M, Zecca M, Maccario R, Salvaneschi L et al. Low incidence of severe acute graft-versus-host in children given haematopoietic stem cell transplantation from unrelated donors prospectively matched for HLA class I and II alleles with high-resolution molecular typing. Bone Marrow Transplant 2003; 31: 987\u2013993.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2014202.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2014202","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2014202.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T18:13:13Z","timestamp":1648059193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2014202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,29]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["BFbmt2014202"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2014.202","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,29]]},"assertion":[{"value":"7 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}